Evidence map›Paper›PMID 11121481›Full record

ArticleNucleic acids research2000

Differential requirements for cis and trans V(D)J cleavage: effects of substrate length.

L E Huye, D B Roth

Abstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

L E HuyeDepartment of Immunology and Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030, USA.
D B Roth

Funding

Mechanisms of V(D) J RecombinationR01AI036420 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTH, DAVID B. · 1994 to 2009
$2.6M
MOLECULAR AND CELLULAR MECHANISMS OF HOST DEFENSET32AI007495 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI TAN, TSE-HUA · 1996 to 2011
$2.4M
NIAID NIH HHS AI-36420NIAID NIH HHS R01 AI036420NIAID NIH HHS T32 AI007495NIAID NIH HHS T32-AI07495
6 · The paper itself

Abstract

The assembly of productive synaptic complexes is a critical, but poorly understood, regulatory step in V(D)J recombination. Several lines of evidence suggest that there may be important differences between recombination involving sites situated in cis (on the same DNA molecule) and in trans (on separate molecules). Because biochemical experiments using both purified RAG proteins and crude extracts have failed to detect trans cleavage of plasmid substrates it has been thought that there is a substantial bias against trans synapsis. In conflict with these results are more recent studies showing that purified RAG proteins can catalyze trans cleavage of short oligonucleotide substrates. Furthermore, recent experiments have detected efficient trans cleavage of plasmid substrates in vivo. We sought to investigate why these different systems yield such divergent results. We found that, unexpectedly, the ability of both purified RAG proteins and crude extracts to cleave DNA substrates in trans is a function of substrate length. Our data raise two critical issues: first, oligonucleotides, which are the most commonly used substrates to study V(D)J recombination in vitro, do not mimic the behavior of plasmid substrates; second, in the trans cleavage reaction current purified RAG systems do not accurately reflect the in vivo situation. We propose a unifying model to explain the effects of substrate length and coniguration (cis or trans) on the efficiency of synapsis.

Indexed as

AnimalsCell ExtractsCHO CellsCricetinaeDNADNA-Binding ProteinsGene RearrangementHomeodomain ProteinsImmunoglobulin Joining RegionImmunoglobulin Variable RegionMolecular WeightOligodeoxyribonucleotidesPlasmidsRecombination, GeneticSubstrate SpecificityCell ExtractsDNADNA-Binding ProteinsHomeodomain ProteinsImmunoglobulin Joining RegionImmunoglobulin Variable RegionOligodeoxyribonucleotidesRAG-1 proteinV(D)J recombination activating protein 2

Identifiers

PMID11121481
PMCPMC115234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.